A new treatment for a common painful condition and two other drugs will be made cheaper to improve access to treatment for ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

A new treatment for a common painful condition and two other drugs will be made cheaper to improve thousands of Australian ...

Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

The Albanese government will make treatments for IVF and endometriosis cheaper as the government rolls out further ...

Thousands of Australian women will soon save hundreds – and in some cases, thousands – of dollars a year for fertility, ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...

Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...